Seroquel

Pharma

AstraZeneca escapes 1 of 2 Seroquel pay-for-delay claims

A federal judge said a $107 million value isn't sufficiently "large" or "justified" to sustain an antitrust claim for Seroquel XR.
Angus Liu Jul 8, 2022 11:58am

AZ sells U.S., Canada Seroquel rights to Cheplapharm for $42M

Dec 3, 2019 12:22pm

AstraZeneca's rummage sale continues with second deal in a week

Nov 6, 2018 10:08am

AZ shells out $110M to wrap up Seroquel, Crestor marketing suits

Aug 8, 2018 10:35am

FiercePharmaAsia—Takeda-Shire, HKEX and more

May 11, 2018 9:55am

AstraZeneca revives yard-sale strategy with Seroquel rights sale

May 8, 2018 12:29pm